| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.3M | — |
| R&D Expense | $41.2M | -21.0% |
| SG&A Expense | $24.8M | -8.2% |
| Operating Income | -$60.6M | +23.4% |
| Income Tax | $0 | — |
| Net Income | -$58.2M | +23.8% |
| EPS (Basic) | -$1.09 | +60.8% |
| EPS (Diluted) | -$1.09 | +60.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $55.3M | +23.7% |
| Current Assets | $60.2M | +25.2% |
| Total Assets | $71.1M | +16.7% |
| Current Liabilities | $27.3M | +70.8% |
| Total Liabilities | $53.5M | +121.9% |
| Stockholders' Equity | $17.6M | -52.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.4M | +73.2% |
| Capital Expenditures | $36K | -92.6% |
| Investing Cash Flow | -$36K | +92.6% |
| Financing Cash Flow | $29.2M | +545.7% |
| Free Cash Flow | -$18.4M | +73.4% |